PLGA Microparticles Encapsulating Prostaglandin El-Hydroxypropyl-B-Cyclodextrin(PGEl-HPBCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)

F Ahsan, M Davis, V Gupta, Louisa Hope-Weeks

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1733-1749
JournalPharmaceutical Research
StatePublished - 2011

Fingerprint Dive into the research topics of 'PLGA Microparticles Encapsulating Prostaglandin El-Hydroxypropyl-B-Cyclodextrin(PGEl-HPBCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)'. Together they form a unique fingerprint.

  • Cite this